DB17675Investigational
Vanglusagene ensiparvovec: Overview.
- Also known as
- recombinant adeno-associated viral (AAV) vector that contains a bio-engineered capsid (AAV-Spark100) and a codon-optimized expression cassette to drive expression of a secretable form of human acid a-glucosidase (GAA) · RG-6359 · SPK 3006 · SPK-3006 · SPK3006
Resolves to
Compound
What you can answer from here — as of September 25, 2025
Which companies are running trials of Vanglusagene ensiparvovec, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account